Major role for ACE-independent intrarenal ANG II formation in type II diabetes.

作者: Sungmi Park , Benjamin J. Bivona , Hiroyuki Kobori , Dale M. Seth , Mark C. Chappell

DOI: 10.1152/AJPRENAL.00519.2009

关键词:

摘要: Combination therapy of angiotensin-converting enzyme (ACE) inhibition and AT(1) receptor blockade has been shown to provide greater renoprotection than ACE inhibitor alone in human diabetic nephropathy, suggesting that ACE-independent pathways for ANG II formation are major significance disease progression. Studies were performed determine the magnitude intrarenal type diabetes. Although renal cortical protein activity [2.1 +/- 0.8 vs. 9.2 2.1 arbitrary fluorescence units (AFU) x mg(-1) min(-1)] intensity immunohistochemical staining significantly reduced ACE2 (16.7 3.2 7.2 2.4 AFU min(-1)) elevated, kidney I (113 24 110 45 fmol/g) (1,017 165 788 99 levels not different between control mice. Afferent arteriole vasoconstriction due conversion was similar kidneys (-28 3% at 1 microM) (-23 mice; a response completely inhibited by blockade. In kidneys, afferent produced attenuated inhibition, but serine protease inhibition. contrast, kidneys. conclusion, there is switch from ACE-dependent protease-dependent kidney. Pharmacological targeting these may further protection vascular disease.

参考文章(49)
H Urata, A Kinoshita, K S Misono, F M Bumpus, A Husain, Identification of a highly specific chymase as the major angiotensin II-forming enzyme in the human heart. Journal of Biological Chemistry. ,vol. 265, pp. 22348- 22357 ,(1990) , 10.1016/S0021-9258(18)45712-2
L. M. Harrison-Bernard, L. G. Navar, M. M. Ho, G. P. Vinson, S. S. el-Dahr, Immunohistochemical localization of ANG II AT1 receptor in adult rat kidney using a monoclonal antibody American Journal of Physiology-renal Physiology. ,vol. 273, ,(1997) , 10.1152/AJPRENAL.1997.273.1.F170
DAISUKE KOYA, MASAKAZU HANEDA, HIROKO NAKAGAWA, KEIJI ISSHIKI, HARUHISA SATO, SHIRO MAEDA, TOSHIRO SUGIMOTO, HITOSHI YASUDA, ATSUNORI KASHIWAGI, D. KIRK WAYS, GEORGE L. KING, RYUICHI KIKKAWA, Amelioration of accelerated diabetic mesangial expansion by treatment with a PKC β inhibitor in diabetic db/db mice, a rodent model for type 2 diabetes The FASEB Journal. ,vol. 14, pp. 439- 447 ,(2000) , 10.1096/FASEBJ.14.3.439
M. Epstein, P. M. Ter Wee, H. G. Forster, Video-microscopic Assessment of the Role of Tissue Angiotensin-converting Enzyme in the Control of the Renal Microcirculation Journal of Pharmacology and Experimental Therapeutics. ,vol. 281, pp. 434- 439 ,(1997)
Lisa M. Harrison-Bernard, Anthony K. Cook, Michael I. Oliverio, Thomas M. Coffman, Renal segmental microvascular responses to ANG II in AT1A receptor null mice American Journal of Physiology-renal Physiology. ,vol. 284, ,(2003) , 10.1152/AJPRENAL.00340.2002
Vivek P Singh, Bao Le, Vadiraja B Bhat, Kenneth M Baker, Rajesh Kumar, None, High-glucose-induced regulation of intracellular ANG II synthesis and nuclear redistribution in cardiac myocytes. American Journal of Physiology-heart and Circulatory Physiology. ,vol. 293, ,(2007) , 10.1152/AJPHEART.00391.2007
Hiroyuki Kobori, Lisa M. Harrison-Bernard, L. Gabriel Navar, Urinary excretion of angiotensinogen reflects intrarenal angiotensinogen production. Kidney International. ,vol. 61, pp. 579- 585 ,(2002) , 10.1046/J.1523-1755.2002.00155.X
Yumei Feng, Xinping Yue, Huijing Xia, Sharell M. Bindom, Peter J. Hickman, Catalin M. Filipeanu, Guangyu Wu, Eric Lazartigues, Angiotensin-converting enzyme 2 overexpression in the subfornical organ prevents the angiotensin II-mediated pressor and drinking responses and is associated with angiotensin II type 1 receptor downregulation. Circulation Research. ,vol. 102, pp. 729- 736 ,(2008) , 10.1161/CIRCRESAHA.107.169110
MJ Soler, J Wysocki, M Ye, J Lloveras, Y Kanwar, D Batlle, None, ACE2 inhibition worsens glomerular injury in association with increased ACE expression in streptozotocin-induced diabetic mice. Kidney International. ,vol. 72, pp. 614- 623 ,(2007) , 10.1038/SJ.KI.5002373
Hiroyuki Kobori, Akira Nishiyama, Lisa M. Harrison-Bernard, L. Gabriel Navar, Urinary Angiotensinogen as an Indicator of Intrarenal Angiotensin Status in Hypertension Hypertension. ,vol. 41, pp. 42- 49 ,(2003) , 10.1161/01.HYP.0000050102.90932.CF